Pharmaceuticals - Community Register

  

Community register of orphan medicinal products


GRANTED  

Product information

Pralatrexate

EU orphan designation number: EU/3/08/603   
Active ingredient: Pralatrexate
Indication: Treatment of non-papillary transitional cell carcinoma of the urinary bladder
Sponsor: Allos Therapeutics Limited
71 Knowl Piece, Wilbury Way, Hitchin, Hertfordshire SG4 0TY, United Kingdom

   Public summary of scientific opinion    

 

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
21/01/2009 Centralised Orphan - Designation EMEA/OD/074/08 (2009)389 of 19/01/2009
18/02/2010 Centralised Orphan - Transfer of orphan designation EMEA/OD/074/08/T/01 (2010)965 of 12/02/2010
18/08/2010 Other procedure EMA/408875/2010